On November 11, 2014, the peer-reviewed Journal of Psychopharmacology published a paper describing the results of a qualitative study of subjects in our completed Swiss Phase 2 pilot study of LSD-assisted …
On May 16, 2014, the annual report for LSD-assisted psychotherapy for anxiety associated with advanced-stage illness was submitted to the U.S. Food and Drug Administration. The required report provides …
On March 4, 2014, the results of the first study of the therapeutic use of lysergic acid diethylamide (LSD) in humans in over 40 years were published online in the peer-reviewed Journal of Nervous and …
On March 4, 2014, the results of our completed study of the therapeutic use of lysergic acid diethylamide (LSD) to treat anxiety associated with advanced-stage illness were published online in the peer-reviewed …
On December 23, 2013, the results of our completed Swiss study of LSD-assisted psychotherapy for anxiety associated with life-threatening illness were accepted for publication in the peer-reviewed Journal …
On September 17, 2013, the Final Report for our completed Swiss study of LSD-assisted psychotherapy for anxiety associated with advanced stage illness was submitted to Swissmedic. The report contains information …
On August 9, 2013, the results of our completed study of LSD-assisted psychotherapy for anxiety associated with life-threatening illness were resubmitted for publication in a second peer-reviewed journal, …
On June 20, 2013, the paper reporting the results of our completed study of LSD-assisted psychotherapy for anxiety associated with life-threatening illness was submitted for review by a peer-reviewed scientific …
From September 3-7, 2012, MAPS Lead Clinical Research Associate Berra Yazar-Klosinski, Ph.D., visited the study site for our completed Swiss study of LSD-assisted psychotherapy for anxiety associated with …
On August 8, 2012, the last long-term follow-up interview was conducted in our recently completed study of LSD-assisted psychotherapy for anxiety associated with advanced-stage illness in Switzerland. …
Read “Shaping the Renaissance of Psychedelic Research” Ben Sessa writes for The Lancet about the current state of psychedelic research.
On May 2, 2012, the MAPS clinical team submitted to the FDA the annual report (PDF) for our ongoing long-term follow-up to our Swiss study of LSD-assisted psychotherapy for anxiety associated with life-threatening …
